Sex-divergent brain epigenetic reprogramming by chronic opioids

Authors:
  • CFCamille Falconnier
    Camille Falconnier
  • ACAlba Caparros-Roissard
    Alba Caparros-Roissard
  • HSHanus Slavik
    Hanus Slavik
  • MGMithil Gaikwad
    Mithil Gaikwad
  • VMVictor Mathis
    Victor Mathis
  • MDMargot Diringer
    Margot Diringer
  • CDCharles Decraene
    Charles Decraene
  • SMSalim Megat
    Salim Megat
  • SOSebahat Ozkan
    Sebahat Ozkan
  • MYMohamad Yassine
    Mohamad Yassine
  • YHYahia Hadj-Arab
    Yahia Hadj-Arab
  • PHPierre Hener
    Pierre Hener

Abstract
Opioid use disorder (OUD) is a chronic condition that exhibits sex differences in prevalence, symptoms and treatment. Yet, the epigenetic mechanisms underlying these differences remain largely unknown. Here, we investigated the nucleus accumbens, a key brain region in OUD, to define the multiomic consequences of chronic morphine exposure in male and female mice. We profiled DNA methylation, five histone post-translational modifications, and their transcriptional effects at bulk and cell-type-specific levels. Despite comparable tissue organization and neurophysiological responses to morphine, epigenetic adaptations occurred at highly sex-specific genomic loci. These adaptations nevertheless followed common mechanistic principles, acting at similar gene features and transcription factor binding sites across sexes. Strikingly, they converged on overlapping genes, biological functions, and co-expression modules, and partially recapitulated transcriptional signatures of OUD in men and women. Therefore, our findings uncover a profound epigenetic sex divergence that mediates convergent biological dysregulation, and highlight opportunities for developing improved therapeutic strategies tailored to sex-specific mechanisms.

This publication has 136 references indexed in Scilit: